𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis

✍ Scribed by Sawsan J. Hayat; Sukhbir S. Uppal; M. R. Narayanan Nampoory; Kaivilayil V. Johny; Ramkumar Gupta; Mohammed Al-Oun


Publisher
Springer
Year
2006
Tongue
English
Weight
83 KB
Volume
26
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The efficacy and safety of leflunomide i
✍ J. R. Kalden; M. Schattenkirchner; H. SΓΆrensen; P. Emery; C. Deighton; B. Rozman πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 123 KB πŸ‘ 2 views

## Abstract ## Objective To investigate the efficacy and safety of leflunomide beyond 2 years in a multinational, open‐label extension of 2 phase III double‐blind studies. ## Methods Patients with rheumatoid arthritis (RA) who received leflunomide (100 mg/day for 3 days, 10 mg/day or 20 mg/day t